Skip to Main Content

Michael F. Murray, MD, FACMG, FACP

Genetics, Clinical Genetics

Biography

Michael F. Murray, MD, is a medical geneticist and an internist. He is the clinical director of the Yale Center for Genomic Health. He is leading the “Generations Project” with the aim of developing a research cohort of over 100,000 volunteers. This project will seek to learn more about human health and disease by linking genomic and electronic health record data for research. Once fully established, this rich database of information, which will be anonymized, will be available to researchers who will analyze any links between medical history and genetic code. In addition, the team will review the genomic data for certain kinds of changes that could be important for participants and their healthcare providers to know about, and, if found, they will give them back to the participants and support them in understanding and managing those results.

“Access to data like this will be a game changer,” says Dr. Murray. “As this project progresses, researchers will be able to study very specific subgroups of patients in order to find new risk factors and potentially new treatments based on the changes in DNA that link to medical history.”

Titles

  • Professor of Genetics and Pathology

Education & Training

  • Fellow
    Harvard Medical School (2003)
  • Fellow
    University of Pennsylvania (1995)
  • Resident
    Cleveland Clinic (1991)
  • MD
    Pennsylvania State University (1988)

Additional Information

Biography

Michael F. Murray, MD, is a medical geneticist and an internist. He is the clinical director of the Yale Center for Genomic Health. He is leading the “Generations Project” with the aim of developing a research cohort of over 100,000 volunteers. This project will seek to learn more about human health and disease by linking genomic and electronic health record data for research. Once fully established, this rich database of information, which will be anonymized, will be available to researchers who will analyze any links between medical history and genetic code. In addition, the team will review the genomic data for certain kinds of changes that could be important for participants and their healthcare providers to know about, and, if found, they will give them back to the participants and support them in understanding and managing those results.

“Access to data like this will be a game changer,” says Dr. Murray. “As this project progresses, researchers will be able to study very specific subgroups of patients in order to find new risk factors and potentially new treatments based on the changes in DNA that link to medical history.”

Titles

  • Professor of Genetics and Pathology

Education & Training

  • Fellow
    Harvard Medical School (2003)
  • Fellow
    University of Pennsylvania (1995)
  • Resident
    Cleveland Clinic (1991)
  • MD
    Pennsylvania State University (1988)

Additional Information